Filter
1948
Filtered Results: 1948
Text search:
Economic
burden
of
Tuberculosis
Featured
Recommendations
151
New Publications
572
Language
Document type
No document type
1224
Studies & Reports
388
Guidelines
147
Strategic & Response Plan
84
Manuals
61
Fact sheets
15
Training Material
11
Situation Updates
9
Resource Platforms
5
Infographics
4
Countries / Regions
Global
90
India
80
Kenya
70
Western and Central Europe
65
South Africa
54
Ethiopia
52
Nigeria
44
Uganda
43
Zambia
42
Nepal
39
Liberia
38
Africa
37
Malawi
36
Tanzania
36
Eastern Europe
36
Rwanda
30
Bangladesh
27
Ghana
25
Sierra Leone
25
Latin America and the Carribbean
25
Namibia
25
Asia
24
Myanmar / Burma
24
Ukraine
22
Cambodia
22
South–East Asia Region
22
Lesotho
21
Zimbabwe
15
Indonesia
15
Philippines
13
East and Southern Africa
12
Botswana
11
South Sudan
11
Mozambique
10
Congo, Democratic Republic of
8
Haiti
7
West and Central Africa
7
Russia
7
Pakistan
7
Syria
6
Afghanistan
6
Eastern Europe and Central Asia
6
Colombia
5
Cameroon
5
Senegal
5
Burkina Faso
5
Guinea
5
Venezuela
5
Moldova
5
Yemen
5
Somalia
5
Thailand
4
Albania
4
Peru
4
Germany
4
Middle East and North Africa
4
North America
4
Papua New Guinea
4
Sudan
4
Eswatini/ Swaziland
4
Tajikistan
3
Laos
3
Armenia
3
Jordan
3
Western Pacific Region
3
Vietnam
3
Brazil
3
North Macedonia
2
Benin
2
China
2
Chile
2
Turkmenistan
2
Jamaica
2
Southern Africa
2
Argentina
2
Lebanon
2
Sri Lanka
2
Romania
2
Palestine
2
Georgia
2
Timor Leste/ East Timor
1
Mexico
1
Iran
1
Burundi
1
Mongolia
1
Qatar
1
Bulgaria
1
USA
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Bolivia
1
Djibouti
1
Egypt
1
Central African Republic
1
Poland
1
Mali
1
Libya
1
Bhutan
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
823
Public Health
132
Clinical Guidelines
118
Key Resources
49
Women & Child Health
46
Pharmacy & Technologies
16
Capacity Building
13
Annual Report MEDBOX
1
Toolboxes
TB
276
HIV
264
AMR
105
COVID-19
91
Mental Health
63
Global Health Education
53
Planetary Health
52
NCDs
50
Health Financing Toolbox
49
NTDs
31
Rapid Response
29
Caregiver
27
Refugee
25
Disability
23
Conflict
23
Pharmacy
18
Polio
16
Ebola
11
Natural Hazards
8
Cholera
3
Specific Hazards
2
South Sudan
1
Health Financing
1
Journal of the International Association of Providers of AIDS Care 2017, Vol. 16(3) 226–232
Journal of Infection and Public Health 12 (2019) 213–223
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Accessed: 08.11.2020
Int J Health Policy Manag 2017, 6(10), 587–600
Low-income countries face many contextual challenges to manage healthcare technologies effectively, as the majority are imported and resources are constrained to a greater extent. Previous healthcare technology management (HTM) policies in Benin ha...
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Med Princ Pract 2021;30:17–28
An overview of ethics and clinical ethics is presented in this review. The 4 main ethical principles, that is beneficence, nonmaleficence, autonomy, and justice, are defined and explained. Informed consent, truth-telling, and confidentiality spring from the ...
BMC Public Health (2021) 21:299 https://doi.org/10.1186/s12889-021-10296-9
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
INTRODUCTION: Health service use among the public can decline during outbreaks and had been predicted among low and middle-income countries during the COVID-19 pandemic. In March 2020, the government of the Democratic Republic of the Congo (DRC) started implementing public health measures across Kin...
To support countries in adapting their response to different COVID-19 scenarios, the World Health
Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissioned this scoping review of published and grey literature. The objective was to identify interventions...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known about the required training necessary for them to ...
In this version of the compendium, each guidance is coded using the International Classification of Health Interventions (ICHI).
The compendium provides a systematic compilation of published guidance from WHO and other UN organizations on health and environment. Guidance on policies and actions a...
January – December 2014
Republic of Moldova South‐East European Region National Coordination Council
Declaration of Commitment of the United Nations General Assembly Special Session on HIV/AIDS
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
